MedTrace Logo

Trial of Folic Acid Effect on Hcy and cIMT After Kidney Tx

NCT00570856 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2007-12-19

No results posted yet for this study

Summary

To see the effect of Folic acid supplementation after kidney transplantation on plasma total homocysteine level and carotid intimal-media thickness

Conditions

  • Kidney Transplantation

Interventions

DRUG

Folic acid

Folic acid 5 mg/day

DRUG

Placebo

Placebo similar to the folic acid tablets, 1/day

Sponsors & Collaborators

  • Shahid Beheshti University of Medical Sciences

    lead OTHER

Principal Investigators

  • Mohsen Nafar, MD- Nephrologist · Urology Nephrology Research Center, Labbafi Nejad Hospital, Shaheed Beheshti University of Medical Sciences, Tehran, Iran

  • Farideh Khatami, Master of Science · Labbafi Nejad Hospital, Shaheed Beheshti University of Medical Sciences, Tehran, Iran

  • Babak Kardavani, M.D. · Urology Nephrology Research Center, Labbafi Nejad Hospital, Shaheed Beheshti University of Medical Sciences, Tehran, Iran

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-06-30
Completion
2006-03-31

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00570856 on ClinicalTrials.gov